Patents by Inventor Joshua C. Murtie

Joshua C. Murtie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENTS FOR NEUROPATHY
    Publication number: 20160058749
    Abstract: Small fiber neuropathy is treated or prevented by topically administering to a subject in need thereof topically active quinoline compounds or pharmaceutically acceptable salts thereof under conditions effective to treat or prevent neuropathy in the subject. Glial cell-derived neurotrophic factor (GDNF) receptors are modulated with the subject active quinoline compounds, which may be formulated in topical lotions.
    Type: Application
    Filed: November 9, 2015
    Publication date: March 3, 2016
    Inventors: Gabriel Corfas, Joshua C. Murtie
  • Treatments for Neuropathy
    Publication number: 20110086878
    Abstract: Small fiber neuropathy is treated or prevented by topically administering to a subject in need thereof topically active quinoline compounds or pharmaceutically acceptable salts thereof under conditions effective to treat or prevent neuropathy in the subject. Glial cell-derived neurotrophic factor (GDNF) receptors are modulated with the subject active quinoline compounds, which may be formulated in topical lotions.
    Type: Application
    Filed: December 16, 2010
    Publication date: April 14, 2011
    Inventors: Gabriel Corfas, Joshua C. Murtie
  • Treatments for neuropathy
    Patent number: 7863295
    Abstract: Small fiber neuropathy is treated by topically administering to a subject in need thereof topically active quinoline compounds or pharmaceutically acceptable salts thereof under conditions effective to treat neuropathy in the subject. Glial cell-derived neurotrophic factor (GDNF) receptors are modulated with the subject active quinoline compounds, which may be formulated in topical lotions.
    Type: Grant
    Filed: January 8, 2009
    Date of Patent: January 4, 2011
    Assignee: Children's Medical Center Corporation
    Inventors: Gabriel Corfas, Joshua C. Murtie
  • TREATMENTS FOR NEUROPATHY
    Publication number: 20090203735
    Abstract: Small fiber neuropathy is treated or prevented by topically administering to a subject in need thereof topically active quinoline compounds or pharmaceutically acceptable salts thereof under conditions effective to treat or prevent neuropathy in the subject. Glial cell-derived neurotrophic factor (GDNF) receptors are modulated with the subject active quinoline compounds, which may be formulated in topical lotions.
    Type: Application
    Filed: January 8, 2009
    Publication date: August 13, 2009
    Inventors: Gabriel Corfas, Joshua C. Murtie